Key statistics
On Friday, Kronos Bio Inc (KRON:NSQ) closed at 0.903, 30.87% above the 52 week low of 0.69 set on May 24, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.92 |
---|---|
High | 0.92 |
Low | 0.88 |
Bid | 0.8703 |
Offer | 0.939 |
Previous close | 0.8743 |
Average volume | 318.27k |
---|---|
Shares outstanding | 60.29m |
Free float | 44.07m |
P/E (TTM) | -- |
Market cap | 52.72m USD |
EPS (TTM) | -1.44 USD |
Data delayed at least 15 minutes, as of Nov 22 2024 21:00 GMT.
More ▼
- Kronos Bio Highlights Preclinical Data that Show p300 KAT Inhibitors Reduce Inflammation in an Oral Presentation at ACR Convergence 2024
- Kronos Bio Reports Third Quarter 2024 Financial Results and Corporate Update Including Plan to Evaluate Strategic Alternatives
- Kronos Bio to Present Data at the ASH Annual Meeting from p300 KAT Inhibition Program in Multiple Myeloma
- Kronos Bio Data Presentation at EORTC-NCI-AACR Symposium Highlights the Importance of p300 KAT Inhibition in HPV-Driven Tumors
- Kronos Bio to Present Data at the EORTC-NCI-AACR Symposium that Supports p300 KAT Inhibition in HPV-Driven Tumors
- Kronos Bio Announces Selection of Autoimmune Development Candidate for Sjögren’s Disease
- Kronos Bio to Present Data at ACR Convergence 2024 to Support p300 KAT Inhibition as an Approach to Anti-Inflammatory Therapy
- Kronos Bio Highlights Data at AACR Ovarian Cancer Research Symposium that Supports Clinical Evaluation of Istisociclib in Advanced Ovarian Cancer
- Kronos Bio Announces Participation in Medical and Investor Conferences in September
- Kronos Bio Reports Second Quarter 2024 Financial Results and Pipeline Update
More ▼